Synthesis and Positron Emission Tomography Evaluation of Three Norepinephrine Transporter Radioligands: [C-11]Desipramine, [C-11]Talopram and [C-11]Talsupram Magnus SchouJudit SóvágóChrister Halldin Original Article 02 December 2005 Pages: 1 - 8
Longitudinal MicroPET Imaging of Brain Tumor Growth with F-18-labeled RGD Peptide Xiaoyuan ChenRyan ParkPeter S. Conti Original Article 29 November 2005 Pages: 9 - 15
Combined I-124 Positron Emission Tomography/Computed Tomography Imaging of NIS Gene Expression in Animal Models of Stably Transfected and Intravenously Transfected Tumor David DingliBrad J. KempVal J. Lowe Original Article 19 November 2005 Pages: 16 - 23
Reduction of Brown Fat 2-Deoxy-2-[F-18]fluoro-d-glucose Uptake by Controlling Environmental Temperature Prior to Positron Emission Tomography Scan Carlos A. GarciaDouglas Van NostrandM. Majd Research Article 07 December 2005 Pages: 24 - 29
Use of Positron Emission Tomography to Target Prostate Cancer Gene Therapy by Oncolytic Herpes Simplex Virus Michael MulleradDavid P. EisenbergYuman Fong Research Article 16 December 2005 Pages: 30 - 35
Usefulness of 3′-[F-18]Fluoro-3′-deoxythymidine with Positron Emission Tomography in Predicting Breast Cancer Response to Therapy Betty S. PioCecilia K. ParkDaniel H. S. Silverman Research Article 14 December 2005 Pages: 36 - 42
Positron Emission Tomography/Computed Tomography with F-18-fluorocholine for Restaging of Prostate Cancer Patients: Meaningful at PSA < 5 ng/ml? Martin HeinischAlbert DirisamerWerner Langsteger Original Article 29 November 2005 Pages: 43 - 48